Chapter 93- Chronic Leukemias and Multiple Myeloma

Description:
IMPORTANT NOTE – PLEASE READ FIRST: This continuing education assessment requires that you first purchase the text book: Pharmacotherapy Principles & Practice. Please go to our home page: http://www.rxugace.com/ and click on “Books” for more information Prior To Registering for this assessment.

Upon completion of the corresponding textbook chapter in Pharmacotherapy Principles & Practice and this on-line assessment, the reader should be able to:

1. Explain the role of the Philadelphia chromosome in the pathophysiology of chronic myelogenous leukemia (CML).
2. Describe the natural history of chronic myelogenous leukemia (CML).
3. Identify the clinical signs and symptoms associated with chronic myelogenous leukemia (CML).
4. Discuss treatment options for chronic myelogenous leukemia (CML) with special emphasis on imatinib.
5. Describe the clinical course of chronic lymphocytic leukemia (CLL).
6. Describe patients who may be observed without treatment and those who receive aggressive treatment for chronic lymphocytic leukemia (CLL).
7. Discuss the various treatment options available for chronic lymphocytic leukemia (CLL).
8. Describe the clinical presentation of multiple myeloma.
9. Discuss treatment options available for multiple myeloma.

Courses Offered